Skip to main content

Find Clinical Trials

Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,006 public trials 1,218 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma

NCT01078961

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients

NCT01588769

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations: Department of Neurosurgery, Rigshospitalet Copenhagen, Denmark

View Trial Details

Completed

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

NCT01183663

Conditions: Adenocarcinoma, Advanced Cancers, Astrocytoma, +68 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA

NCT01833273

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiform (Grade IV Astrocytoma), +8 more
Locations: Stony Brook University Medical Center Stony Brook, New York, United States

View Trial Details

Completed

An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk

NCT01508013

Conditions: Carcinoma, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, +16 more
Locations: East Tennessee State University Johnson City, Tennessee, United States

View Trial Details

Completed

Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery

NCT00416767

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +24 more
Locations: Not specified

View Trial Details

Completed

Assessing Psychosocial and Supportive Care Needs in Patients With Gliomas

NCT02728024

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Not specified

View Trial Details

Completed

Cellular Immunotherapy Study for Brain Cancer

NCT01144247

Conditions: Anaplastic Astrocytoma, Anaplastic Mixed Glioma, Anaplastic Oligodendroglioma, +29 more
Locations: University of California, Los Angeles Los Angeles, California, United States

View Trial Details

Completed

Quality of Life and Surgical Late Effects of Melanoma Treatment

NCT02352623

Conditions: Anxiety, Anxiety Disorders, Behavior, +26 more
Locations: Department of Plastic Surgery, Herlev Hospital Herlev, Denmark

View Trial Details

Completed

Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma

NCT01435499

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details